June 29, 2026 05:11 PM EDT PharmaFDA+ NEJM retracts pivotal data for Amgen's Tavneos Nicole DeFeudis Senior Reporter Pivotal data for Amgen’s Tavneos have been retracted from the New England Journal of Medicine, creating another obstacle for the beleaguered autoimmune drug. Two academic … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
78 words · extracted 19d agoread original ↗
comments(0)
5-min edit window · permanent after that